Connection

Co-Authors

Back to Details
This is a "connection" page, showing publications co-authored by Antonietta Coppola and Anna Annunziata.
Antonietta Coppola
Connection Strength
1.508
Anna Annunziata
  1. The Angiotensin Converting Enzyme Deletion/Deletion Genotype Is a Risk Factor for Severe COVID-19: Implication and Utility for Patients Admitted to Emergency Department. Medicina (Kaunas). 2021 Aug 20; 57(8).
    View in: PubMed
    Score: 0.241
  2. Alpha-1 Antitrypsin Deficiency: Home Therapy. Front Pharmacol. 2021; 12:575402.
    View in: PubMed
    Score: 0.235
  3. Bleeding events in COVID-19: the other side of the coin? Monaldi Arch Chest Dis. 2021 Apr 01; 91(3).
    View in: PubMed
    Score: 0.234
  4. Home Management of Patients with Moderate or Severe Respiratory Failure Secondary to COVID-19, Using Remote Monitoring and Oxygen with or without HFNC. Pathogens. 2021 Apr 01; 10(4).
    View in: PubMed
    Score: 0.234
  5. Late Reactivation of SARS-CoV-2: A Case Report. Front Med (Lausanne). 2020; 7:531.
    View in: PubMed
    Score: 0.225
  6. Pulmonary Embolism in Covid-19: Coagulation Parameters, Close Monitoring to Prevent? Turk Thorac J. 2020 Jul; 21(4):287-288.
    View in: PubMed
    Score: 0.222
  7. The Role of High Flow Nasal Cannula in COVID-19 Associated Pneumomediastinum and Pneumothorax. Healthcare (Basel). 2021 May 22; 9(6).
    View in: PubMed
    Score: 0.059
  8. ACE Gene I/D Polymorphism and Acute Pulmonary Embolism in COVID19 Pneumonia: A Potential Predisposing Role. Front Med (Lausanne). 2020; 7:631148.
    View in: PubMed
    Score: 0.058
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.